downgraded at Wells Fargo from Outperform to Market Perform. Valuation call, as the company's growth in the Bakken shale faces operational hurdles.
STOCK COMMENTS / EPS CHANGES
(AMZN - Get Report)
price target boosted at Credit Suisse to $145 from $115. In-line 3Q earnings, company appears to be in a reinvestment cycle. Maintain Neutral rating.
(AMZN - Get Report)
estimates cut at Barclays. AMZN 2010 and 2011 EPS estimates dropped to $2.41 and $3.18, respectively. Strong holiday season expected, but will likely come with higher costs. Maintain Overweight rating and $180 target.
estimates increased at Morgan Stanley through 2012. Company is seeing higher fee income and lower loss provisions. Overweight rating and $52 price target.
estimates, target boosted at Citigroup. Shares of BAX now seen reaching $45. Estimates also upped, because of better organic sales growth. Sell rating.
estimates, target raised at Morgan Stanley. Shares of BAX now seen reaching $56. Estimates also increased, given a sharper IVIG recovery. Overweight rating.
estimates, target reduced at UBS. BBT estimates were lowered through 2012. Company continues to realize higher credit losses. Neutral rating and new $23 price target.
price target higher at Credit Suisse. CA price target raised to $22 from $20. Solid 2Q results with strong bookings driven by distribution business. Maintain Neutral rating.
price target boosted at Barclays. CAT price target increased to $85 from $76. Solid 3Q10 beat and raised outlook for the remainder of the year on continued end-market momentum. Maintain Equal Weight rating.
estimates, target boosted at Morgan Stanley. Shares of CAT now seen reaching $100. Estimates also increased, as better engine sales are driving higher margins. Overweight rating.
estimates, target raised at UBS. Shares of CB now seen reaching $64. Estimates also increased, given reserve releases. Buy rating.
target raised, estimates changed at Barclays. CBE price target increased to $63 from $60 on strong results with bullish 2011 outlook. 2010 EPS estimate trimmed to $3.19, 2011 lifted to $3.70. Maintain Overweight rating.
numbers upped at Morgan Stanley. CBE estimates were raised through 2012. Company is delivering strong organic sales growth. Overweight rating and new $63 price target.
estimates, target raised at Morgan Stanley. Shares of COST now seen reaching $71. Estimates also increased, given renewed store and membership fee growth. Overweight rating.